Cargando…

His-FLAG Tag as a Fusion Partner of Glycosylated Human Interferon-Gamma and Its Mutant: Gain or Loss?

In order to obtain glycosylated human interferon-gamma (hIFNγ) and its highly prone to aggregation mutant K88Q, a secretory expression in insect cells was employed. To facilitate recombinant proteins purification, detection, and stability the baculovirus expression vectors were constructed to bear N...

Descripción completa

Detalles Bibliográficos
Autores principales: Krachmarova, Elena, Tileva, Milena, Lilkova, Elena, Petkov, Peicho, Maskos, Klaus, Ilieva, Nevena, Ivanov, Ivan, Litov, Leandar, Nacheva, Genoveva
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5480026/
https://www.ncbi.nlm.nih.gov/pubmed/28685146
http://dx.doi.org/10.1155/2017/3018608
_version_ 1783245218482487296
author Krachmarova, Elena
Tileva, Milena
Lilkova, Elena
Petkov, Peicho
Maskos, Klaus
Ilieva, Nevena
Ivanov, Ivan
Litov, Leandar
Nacheva, Genoveva
author_facet Krachmarova, Elena
Tileva, Milena
Lilkova, Elena
Petkov, Peicho
Maskos, Klaus
Ilieva, Nevena
Ivanov, Ivan
Litov, Leandar
Nacheva, Genoveva
author_sort Krachmarova, Elena
collection PubMed
description In order to obtain glycosylated human interferon-gamma (hIFNγ) and its highly prone to aggregation mutant K88Q, a secretory expression in insect cells was employed. To facilitate recombinant proteins purification, detection, and stability the baculovirus expression vectors were constructed to bear N-terminal His(6)-FLAG tag. Although the obtained proteins were glycosylated, we found that their biological activity was 100 times lower than expected. Our attempts to recover the biological properties of both proteins by tag removal failed due to enterokinase resistance of the tag. Surprisingly, the tag was easily cleaved when the proteins were expressed in E. coli cells and the tag-free proteins showed fully restored activity. To shed light on this phenomenon we performed molecular dynamics simulations. The latter showed that the tags interact with the receptor binding domains and the flexible C-termini of the fusion proteins thus suppressing their complex formation with the hIFNγ receptor. We hypothesize that in the case of glycosylated proteins the tag/C-terminal interaction positions the FLAG peptide in close proximity to the glycans thus sterically impeding the enterokinase access to its recognition site.
format Online
Article
Text
id pubmed-5480026
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher Hindawi
record_format MEDLINE/PubMed
spelling pubmed-54800262017-07-06 His-FLAG Tag as a Fusion Partner of Glycosylated Human Interferon-Gamma and Its Mutant: Gain or Loss? Krachmarova, Elena Tileva, Milena Lilkova, Elena Petkov, Peicho Maskos, Klaus Ilieva, Nevena Ivanov, Ivan Litov, Leandar Nacheva, Genoveva Biomed Res Int Research Article In order to obtain glycosylated human interferon-gamma (hIFNγ) and its highly prone to aggregation mutant K88Q, a secretory expression in insect cells was employed. To facilitate recombinant proteins purification, detection, and stability the baculovirus expression vectors were constructed to bear N-terminal His(6)-FLAG tag. Although the obtained proteins were glycosylated, we found that their biological activity was 100 times lower than expected. Our attempts to recover the biological properties of both proteins by tag removal failed due to enterokinase resistance of the tag. Surprisingly, the tag was easily cleaved when the proteins were expressed in E. coli cells and the tag-free proteins showed fully restored activity. To shed light on this phenomenon we performed molecular dynamics simulations. The latter showed that the tags interact with the receptor binding domains and the flexible C-termini of the fusion proteins thus suppressing their complex formation with the hIFNγ receptor. We hypothesize that in the case of glycosylated proteins the tag/C-terminal interaction positions the FLAG peptide in close proximity to the glycans thus sterically impeding the enterokinase access to its recognition site. Hindawi 2017 2017-06-08 /pmc/articles/PMC5480026/ /pubmed/28685146 http://dx.doi.org/10.1155/2017/3018608 Text en Copyright © 2017 Elena Krachmarova et al. https://creativecommons.org/licenses/by/4.0/ This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research Article
Krachmarova, Elena
Tileva, Milena
Lilkova, Elena
Petkov, Peicho
Maskos, Klaus
Ilieva, Nevena
Ivanov, Ivan
Litov, Leandar
Nacheva, Genoveva
His-FLAG Tag as a Fusion Partner of Glycosylated Human Interferon-Gamma and Its Mutant: Gain or Loss?
title His-FLAG Tag as a Fusion Partner of Glycosylated Human Interferon-Gamma and Its Mutant: Gain or Loss?
title_full His-FLAG Tag as a Fusion Partner of Glycosylated Human Interferon-Gamma and Its Mutant: Gain or Loss?
title_fullStr His-FLAG Tag as a Fusion Partner of Glycosylated Human Interferon-Gamma and Its Mutant: Gain or Loss?
title_full_unstemmed His-FLAG Tag as a Fusion Partner of Glycosylated Human Interferon-Gamma and Its Mutant: Gain or Loss?
title_short His-FLAG Tag as a Fusion Partner of Glycosylated Human Interferon-Gamma and Its Mutant: Gain or Loss?
title_sort his-flag tag as a fusion partner of glycosylated human interferon-gamma and its mutant: gain or loss?
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5480026/
https://www.ncbi.nlm.nih.gov/pubmed/28685146
http://dx.doi.org/10.1155/2017/3018608
work_keys_str_mv AT krachmarovaelena hisflagtagasafusionpartnerofglycosylatedhumaninterferongammaanditsmutantgainorloss
AT tilevamilena hisflagtagasafusionpartnerofglycosylatedhumaninterferongammaanditsmutantgainorloss
AT lilkovaelena hisflagtagasafusionpartnerofglycosylatedhumaninterferongammaanditsmutantgainorloss
AT petkovpeicho hisflagtagasafusionpartnerofglycosylatedhumaninterferongammaanditsmutantgainorloss
AT maskosklaus hisflagtagasafusionpartnerofglycosylatedhumaninterferongammaanditsmutantgainorloss
AT ilievanevena hisflagtagasafusionpartnerofglycosylatedhumaninterferongammaanditsmutantgainorloss
AT ivanovivan hisflagtagasafusionpartnerofglycosylatedhumaninterferongammaanditsmutantgainorloss
AT litovleandar hisflagtagasafusionpartnerofglycosylatedhumaninterferongammaanditsmutantgainorloss
AT nachevagenoveva hisflagtagasafusionpartnerofglycosylatedhumaninterferongammaanditsmutantgainorloss